<DOC>
	<DOCNO>NCT00519987</DOCNO>
	<brief_summary>This open label , single-center study pharmacokinetic safety profile repeat dose PMI-150 ( intranasal ketamine ) 30 mg healthy adult volunteer .</brief_summary>
	<brief_title>Multiple Dose Pharmacokinetics Intranasal Ketamine</brief_title>
	<detailed_description>To examine safety characterize repeat dose plasma profile , effect absorption , accumulation follow repeat administration 30 mg dos PMI-150 ( intranasal ketamine ) healthy adult volunteer .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy adult 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>pharmacokinetics</keyword>
</DOC>